QC
AZN icon

Quent Capital’s AstraZeneca AZN Stock Holding History

Quent Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Sell
553
-29
-5% -$5.59K 0.01% 532
2025
Q4 		$107K Sell
582
-11
-2% -$1.93K 0.01% 542
2025
Q3 		$90.9K Buy
+593
New +$89.8K 0.01% 460
2025
Q2 		– Sell
-648
Closed -$95.3K – 368
2025
Q1 		$95.3K Sell
648
-32
-5% -$4.63K 0.01% 408
2024
Q4 		$89.1K Sell
680
-14
-2% -$1.96K 0.01% 444
2024
Q3 		$108K Buy
694
+18
+3% +$2.91K 0.01% 483
2024
Q2 		$105K Buy
676
+9
+1% +$1.35K 0.01% 449
2024
Q1 		$90.4K Buy
667
+204
+44% +$27K 0.01% 508
2023
Q4 		$62.3K Buy
463
+92
+25% +$12K 0.01% 567
2023
Q3 		$50.2K Buy
371
+1
+0.3% +$137 0.01% 586
2023
Q2 		$52.9K Buy
370
+11
+3% +$1.62K 0.01% 583
2023
Q1 		$49.8K Buy
359
+1
+0.3% +$135 0.01% 600
2022
Q4 		$48.5K Sell
358
-146
-29% -$18.3K 0.01% 590
2022
Q3 		$55K Hold
504
– – 0.01% 517
2022
Q2 		$67K Buy
504
+36
+8% +$4.72K 0.01% 442
2022
Q1 		$62K Buy
468
+200
+75% +$24K 0.01% 539
2021
Q4 		$31K Buy
+268
New +$31.5K 0.01% 640

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Quent Capital's AZN Position: Q1 2026 in Review

Quent Capital reduced its AstraZeneca (AZN) stake by 5% in Q1 2026, selling an estimated $5.59K and leaving 553 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #532.

Quent Capital first reported a position in AZN in Q4 2021 and has held it in 17 quarters since. The position peaked at $108K in Q3 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Quent Capital held 553 shares of AstraZeneca worth $107K as of Q1 2026.
  • Quent Capital sold 29 AstraZeneca shares in Q1 2026, an estimated $5.59K.
  • AstraZeneca made up 0.01% of Quent Capital's portfolio in Q1 2026, its #532 holding.
  • Quent Capital first reported a position in AstraZeneca in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's AstraZeneca position peaked at $108K in Q3 2024.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.